by CheckRare Staff | Feb 21, 2024
Davide Martino, MD, McMaster University Department of Medicine, discusses the BASIS clinical trial, a phase 3 study testing marstacimab in patients with hemophilia without inhibitors. Hemophilia is a bleeding disorder that slows the blood clotting...
by CheckRare Staff | Feb 19, 2024
Bernd Kasper, MD, PhD, Mannheim Cancer Center at University of Heidelberg in Germany, and Principal Investigator of the DeFi trial, discusses desmoid tumors and the approval of Ogsiveo (nirogacestat). A desmoid tumor is a benign, locally invasive...
by CheckRare Staff | Feb 17, 2024
Nicole Miller, PhD, Vice President of Molecular Diagnostics at Ultragenyx Pharmaceutics, explains the importance of improving newborn screening and the limitations of current processes. The Recommended Uniform Screening Panel (RUSP) is a list of...
by CheckRare Staff | Feb 16, 2024
« Prev1 / 1Next »Subtypes of CTCL: Mycosis Fungoides and Sézary Syndrome (Full Interview)CTCL: Mycosis Fungoides and Sézary Syndrome Overview (Chapter 1)Diagnosis of Mycosis Fungoides and Sézary Syndrome (Chapter 2)Importance of Accurate Staging When...
by CheckRare Staff | Feb 16, 2024
Wei Ying Jen, MD, of the Department of Leukemia at the University of Texas MD Anderson Cancer Center, discusses Philadelphia chromosome-positive acute lymphoblastic leukemia and treatment options. Philadelphia chromosome (Ph)-positive acute lymphoblastic...
